GeraldVincentMcMahonMD

Hospital Medicine/Hospitalist

Internal Medicine/Faculty Hospitalist-St Joseph's Hospital, Syracuse

Dr. McMahon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
182 Intrepid LN
Brighton Medical Associates
Syracuse, NY 13205
Phone+1 315-218-7020

Fax+1 315-218-7050

CMS Meaningful Use Stage 1 Certification MEDENT EMR/EHR, Community Computer Service, Inc., 2011

PubMed

2109 citations
Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
Gabriele Bergers, Rolf A. Brekken, Gerald McMahon, Thiennu H. Vu, Takeshi Itoh
Nature Cell Biology. 2000-10-01
1617 citations
In Vivo Antitumor Activity of SU11248, a Novel Tyrosine Kinase Inhibitor Targeting Vascular Endothelial Growth Factor and Platelet-derived Growth Factor Receptors Dete...
Dirk B. Mendel, A. Douglas Laird, Xiaohua Xin, Sharianne G. Louie, James G. Christensen
Clinical Cancer Research. 2003-01-01
107 citations
Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models.
Colin Walsh, Isabelle Tanjoni, Sean Uryu, Alok Tomar, Ju-Ock Nam
Cancer Biology & Therapy. 2010-05-15

Harpoon Therapeutics Reports Clinical Progress Across All Four TriTAC® Pipeline Development ProgramsDecember 8th, 2020
Harpoon Therapeutics Reports Third Quarter 2020 Financial Results and Provides Corporate UpdateNovember 4th, 2020